Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 USD | 0.00% | -6.15% | -30.18% |
13/05 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
09/05 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.18% | 112.41Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.22TCr | |
-3.61% | 2.13TCr | |
-5.71% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.86% | 1.68TCr | |
+37.57% | 1.25TCr | |
-26.24% | 808.97Cr |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- Piper Sandler Initiates Coverage on Verona Pharma With Overweight Rating, $31 Price Target